These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 22617584

  • 21. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
    Triunfo S, Crovetto F, Crispi F, Rodriguez-Sureda V, Dominguez C, Nadal A, Peguero A, Gratacos E, Figueras F.
    Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
    [Abstract] [Full Text] [Related]

  • 22. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study.
    Myers JE, Kenny LC, McCowan LM, Chan EH, Dekker GA, Poston L, Simpson NA, North RA, SCOPE consortium.
    BJOG; 2013 Sep; 120(10):1215-23. PubMed ID: 23906160
    [Abstract] [Full Text] [Related]

  • 23. Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testing.
    Espinoza J, Calsavara VF, Kilpatrick S, Rana S, Costantine MM, Boggess K, Wylie BJ, Moore Simas TA, Louis JM, Gaw SL, Murtha A, Wiegand S, Gollin Y, Singh D, Silver RM, Durie DE, Panda B, Norwitz ER, Burd I, Plunkett B, Scott RK, Lemoine E, Thadhani R, Karumanchi SA.
    Am J Obstet Gynecol; 2024 Sep; 231(3):363.e1-363.e11. PubMed ID: 38825028
    [Abstract] [Full Text] [Related]

  • 24. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [Abstract] [Full Text] [Related]

  • 25. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
    Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, Gotsch F, Edwin S, Nien JK, Chaiworapongsa T, Mittal P, Mazaki-Tovi S, Than NG, Gomez R, Hassan SS.
    J Matern Fetal Neonatal Med; 2008 May; 21(5):279-87. PubMed ID: 18446652
    [Abstract] [Full Text] [Related]

  • 26. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ.
    Circulation; 2010 Aug 03; 122(5):478-87. PubMed ID: 20644016
    [Abstract] [Full Text] [Related]

  • 27. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
    Moore Simas TA, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, Maynard SE.
    J Matern Fetal Neonatal Med; 2014 Jul 03; 27(10):1038-48. PubMed ID: 24066977
    [Abstract] [Full Text] [Related]

  • 28. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA, Sakyi SA, Owiredu WK, Ephraim RK, Anto EO.
    BMC Pregnancy Childbirth; 2015 Aug 25; 15():189. PubMed ID: 26303772
    [Abstract] [Full Text] [Related]

  • 29. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Wathén KA, Tuutti E, Stenman UH, Alfthan H, Halmesmäki E, Finne P, Ylikorkala O, Vuorela P.
    J Clin Endocrinol Metab; 2006 Jan 25; 91(1):180-4. PubMed ID: 16263826
    [Abstract] [Full Text] [Related]

  • 30. Midgestation maternal serum 25-hydroxyvitamin D level and soluble fms-like tyrosine kinase 1/placental growth factor ratio as predictors of severe preeclampsia.
    Woodham PC, Brittain JE, Baker AM, Long DL, Haeri S, Camargo CA, Boggess KA, Stuebe AM.
    Hypertension; 2011 Dec 25; 58(6):1120-5. PubMed ID: 21986503
    [Abstract] [Full Text] [Related]

  • 31. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.
    Wikström AK, Larsson A, Eriksson UJ, Nash P, Nordén-Lindeberg S, Olovsson M.
    Obstet Gynecol; 2007 Jun 25; 109(6):1368-74. PubMed ID: 17540809
    [Abstract] [Full Text] [Related]

  • 32. Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy.
    Crovetto F, Figueras F, Triunfo S, Crispi F, Rodriguez-Sureda V, Peguero A, Dominguez C, Gratacos E.
    Fetal Diagn Ther; 2014 Jun 25; 35(4):258-66. PubMed ID: 24714555
    [Abstract] [Full Text] [Related]

  • 33. Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia.
    Akolekar R, de Cruz J, Foidart JM, Munaut C, Nicolaides KH.
    Prenat Diagn; 2010 Mar 25; 30(3):191-7. PubMed ID: 20101671
    [Abstract] [Full Text] [Related]

  • 34. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.
    Crispi F, Llurba E, Domínguez C, Martín-Gallán P, Cabero L, Gratacós E.
    Ultrasound Obstet Gynecol; 2008 Mar 25; 31(3):303-9. PubMed ID: 18058842
    [Abstract] [Full Text] [Related]

  • 35. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction.
    Crispi F, Domínguez C, Llurba E, Martín-Gallán P, Cabero L, Gratacós E.
    Am J Obstet Gynecol; 2006 Jul 25; 195(1):201-7. PubMed ID: 16545329
    [Abstract] [Full Text] [Related]

  • 36. Real-world data on the clinical use of angiogenic factors in pregnancies with placental dysfunction.
    Dathan-Stumpf A, Czarnowsky V, Hein V, Andraczek T, Stepan H.
    Am J Obstet Gynecol; 2022 Feb 25; 226(2S):S1037-S1047.e2. PubMed ID: 33892922
    [Abstract] [Full Text] [Related]

  • 37. First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.
    Bian Z, Shixia C, Duan T.
    PLoS One; 2015 Feb 25; 10(4):e0124684. PubMed ID: 25906026
    [Abstract] [Full Text] [Related]

  • 38. Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia.
    Unal ER, Robinson CJ, Johnson DD, Chang EY.
    Am J Obstet Gynecol; 2007 Aug 25; 197(2):211.e1-4. PubMed ID: 17689655
    [Abstract] [Full Text] [Related]

  • 39. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
    Binder J, Kalafat E, Palmrich P, Pateisky P, Khalil A.
    Am J Obstet Gynecol; 2021 Sep 25; 225(3):305.e1-305.e14. PubMed ID: 33812812
    [Abstract] [Full Text] [Related]

  • 40. Maternal serum levels of soluble fms-like tyrosine kinase-1 and placental growth factor at 20 and 28 weeks of gestational age and the risk of spontaneous preterm birth.
    Sovio U, Gaccioli F, Cook E, Charnock-Jones DS, Smith GCS.
    Am J Obstet Gynecol; 2023 Aug 25; 229(2):164.e1-164.e18. PubMed ID: 36758709
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.